Matches in Wikidata for { <http://www.wikidata.org/entity/Q99550669> ?p ?o ?g. }
Showing items 1 to 31 of
31
with 100 items per page.
- Q99550669 description "artículu científicu espublizáu en setiembre de 2020" @default.
- Q99550669 description "scientific article published on 15 September 2020" @default.
- Q99550669 description "wetenschappelijk artikel" @default.
- Q99550669 description "наукова стаття, опублікована 15 вересня 2020" @default.
- Q99550669 name "Correspondence on 'Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort' by Micheroli et al" @default.
- Q99550669 name "Correspondence on 'Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort' by Micheroli et al" @default.
- Q99550669 type Item @default.
- Q99550669 label "Correspondence on 'Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort' by Micheroli et al" @default.
- Q99550669 label "Correspondence on 'Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort' by Micheroli et al" @default.
- Q99550669 prefLabel "Correspondence on 'Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort' by Micheroli et al" @default.
- Q99550669 prefLabel "Correspondence on 'Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort' by Micheroli et al" @default.
- Q99550669 P1433 Q99550669-ED93CCB2-BD5C-4701-96DC-1B35E75F285C @default.
- Q99550669 P1476 Q99550669-78B94B6C-45EC-40D5-8321-F4EDE79993E4 @default.
- Q99550669 P2093 Q99550669-E604E4DD-3150-4133-80C7-838A51CE5F69 @default.
- Q99550669 P31 Q99550669-D89D201C-A982-43E4-9606-970FF9DF1793 @default.
- Q99550669 P356 Q99550669-0C0DB108-37FE-4048-A57A-EBABF03AC37C @default.
- Q99550669 P50 Q99550669-4C8E6F33-EC0E-4C95-871C-E16FDFD6C949 @default.
- Q99550669 P50 Q99550669-4CE5FA23-4809-43B4-AFA3-050D030667FA @default.
- Q99550669 P577 Q99550669-B3DE6FC6-A255-426F-BE2D-D10A0E2F4577 @default.
- Q99550669 P698 Q99550669-A260FC17-2BEB-46B7-86FD-B933B61288FD @default.
- Q99550669 P356 ANNRHEUMDIS-2020-218779 @default.
- Q99550669 P698 32933918 @default.
- Q99550669 P1433 Q4767876 @default.
- Q99550669 P1476 "Correspondence on 'Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort' by Micheroli et al" @default.
- Q99550669 P2093 "Pui-Ying Leong" @default.
- Q99550669 P31 Q13442814 @default.
- Q99550669 P356 "10.1136/ANNRHEUMDIS-2020-218779" @default.
- Q99550669 P50 Q88152562 @default.
- Q99550669 P50 Q95976897 @default.
- Q99550669 P577 "2020-09-15T00:00:00Z" @default.
- Q99550669 P698 "32933918" @default.